Trials / Conditions / Neoplasms, Rectal
Neoplasms, Rectal
5 registered clinical trials studyying Neoplasms, Rectal — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China NCT06640049 | GlaxoSmithKline | Phase 2 |
| Active Not Recruiting | A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer NCT05723562 | GlaxoSmithKline | Phase 2 |
| Completed | A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human NCT03671369 | GlaxoSmithKline | — |
| Recruiting | Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer NCT03573791 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Completed | Immunoscore in Rectal Cancer NCT02017509 | Providence Health & Services | — |